152 related articles for article (PubMed ID: 33330109)
1. Gene Panel of Persister Cells as a Prognostic Indicator for Tumor Repopulation After Radiation.
Zhao Y; Song Y; Zhao R; Zhao M; Huang Q
Front Oncol; 2020; 10():607727. PubMed ID: 33330109
[TBL] [Abstract][Full Text] [Related]
2. Predicting tumor repopulation through the gene panel derived from radiation resistant colorectal cancer cells.
Song Y; Deng Z; Sun H; Zhao Y; Zhao R; Cheng J; Huang Q
J Transl Med; 2023 Jun; 21(1):390. PubMed ID: 37328854
[TBL] [Abstract][Full Text] [Related]
3. A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data.
Du Z; Zhang T; Lin Y; Dong G; Li A; Wang Z; Zhang Y; Giamas G; Stebbing J; Zhu L; Peng L
Heliyon; 2023 Nov; 9(11):e20708. PubMed ID: 37920509
[TBL] [Abstract][Full Text] [Related]
4. Cancer Cells Enter an Adaptive Persistence to Survive Radiotherapy and Repopulate Tumor.
Zhao Y; Lu T; Song Y; Wen Y; Deng Z; Fan J; Zhao M; Zhao R; Luo Y; Xie J; Hu B; Sun H; Wang Y; He S; Gong Y; Cheng J; Liu X; Yu L; Li J; Li C; Shi Y; Huang Q
Adv Sci (Weinh); 2023 Mar; 10(8):e2204177. PubMed ID: 36658726
[TBL] [Abstract][Full Text] [Related]
5. The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells.
Wang L; Yang Q; Peng S; Liu X
Onco Targets Ther; 2019; 12():5359-5373. PubMed ID: 31371980
[TBL] [Abstract][Full Text] [Related]
6. Survival of bactericidal antibiotic treatment by tolerant persister cells of Klebsiella pneumoniae.
Li Y; Zhang L; Zhou Y; Zhang Z; Zhang X
J Med Microbiol; 2018 Mar; 67(3):273-281. PubMed ID: 29458540
[TBL] [Abstract][Full Text] [Related]
7. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
8. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
[TBL] [Abstract][Full Text] [Related]
9. Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer.
Cabanos HF; Hata AN
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071428
[TBL] [Abstract][Full Text] [Related]
10. Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer.
Raoof S; Mulford IJ; Frisco-Cabanos H; Nangia V; Timonina D; Labrot E; Hafeez N; Bilton SJ; Drier Y; Ji F; Greenberg M; Williams A; Kattermann K; Damon L; Sovath S; Rakiec DP; Korn JM; Ruddy DA; Benes CH; Hammerman PS; Piotrowska Z; Sequist LV; Niederst MJ; Barretina J; Engelman JA; Hata AN
Oncogene; 2019 Sep; 38(37):6399-6413. PubMed ID: 31324888
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Proteomics Identifies Proteins With Importance to Postantibiotic Recovery in Depolarized Persister Cells.
Spanka DT; Konzer A; Edelmann D; Berghoff BA
Front Microbiol; 2019; 10():378. PubMed ID: 30894840
[TBL] [Abstract][Full Text] [Related]
12. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
13. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
[No Abstract] [Full Text] [Related]
14. Redox signaling in drug-tolerant persister cells as an emerging therapeutic target.
Zhang Z; Tan Y; Huang C; Wei X
EBioMedicine; 2023 Mar; 89():104483. PubMed ID: 36827719
[TBL] [Abstract][Full Text] [Related]
15. ATP-Dependent Persister Formation in Escherichia coli.
Shan Y; Brown Gandt A; Rowe SE; Deisinger JP; Conlon BP; Lewis K
mBio; 2017 Feb; 8(1):. PubMed ID: 28174313
[TBL] [Abstract][Full Text] [Related]
16. Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics.
Defraine V; Fauvart M; Michiels J
Drug Resist Updat; 2018 May; 38():12-26. PubMed ID: 29857815
[TBL] [Abstract][Full Text] [Related]
17. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition.
Hangauer MJ; Viswanathan VS; Ryan MJ; Bole D; Eaton JK; Matov A; Galeas J; Dhruv HD; Berens ME; Schreiber SL; McCormick F; McManus MT
Nature; 2017 Nov; 551(7679):247-250. PubMed ID: 29088702
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
19. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
20. A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.
Cameron DR; Shan Y; Zalis EA; Isabella V; Lewis K
J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29941425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
